Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development
Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths worldwide, and an association between altered bile acid (BA) metabolism, down‐regulation of farnesoid X receptor (FXR), which is a master regulator of BA metabolism, and hepatocarcinogenesis has been documented. While global FXR defi...
Main Authors: | Shogo Takahashi, Naoki Tanaka, Tatsuki Fukami, Cen Xie, Tomoki Yagai, Donghwan Kim, Thomas J. Velenosi, Tingting Yan, Kristopher W. Krausz, Moshe Levi, Frank J. Gonzalez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2018-12-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1263 |
Similar Items
-
Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation
by: Daisuke Aibara, et al.
Published: (2022-05-01) -
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
by: Insook Kim, et al.
Published: (2007-12-01) -
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
by: Hideki Mori, et al.
Published: (2022-07-01) -
Feedback repression of PPARα signaling by Let-7 microRNA
by: Tomoki Yagai, et al.
Published: (2021-08-01) -
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
by: Ludovico Abenavoli, et al.
Published: (2020-06-01)